By  Sydney Lupkin AstraZeneca became the second drugmaker to enter a deal with the Trump administration to offer lower prices to Medicaid and to offer some of its drugs at a discount through TrumpRx, a government website to facilitate sales directly to consumers. “In other words the lowest price anywhere in the world, that’s what…